Intel (INTC) Stock Soars 225% but Wall Street Remains Skeptical
Intel's stock surged 225% to $119.84, outperforming Wall Street earnings forecasts with $0.29 EPS and $13.58 billion in Q1 revenue, though analysts remain cautious with a $81.52 average price target. While some institutional investors trimmed holdings, major firms like Vanguard and Capital World expanded stakes, and insiders like EVP April Miller sold shares amid mixed market signals.
Intel’s stock opened at $119.84, marking a 225% increase from its 52-week low of $18.97 and a 531% surge from its lowest point. The company reported first-quarter 2026 earnings per share of $0.29, far exceeding the $0.01 forecast, alongside $13.58 billion in revenue, up 7.4% year-over-year. Management projects Q2 2026 earnings of $0.20 per share, with full-year estimates at $0.63. Despite the rally, Intel’s net margin remains negative at -5.90%, and return on equity stands at just 0.39%, signaling ongoing operational challenges. Institutional investors show mixed activity: Murphy Pohlad Asset Management reduced its stake by 5.5%, selling 8,370 shares, while Vanguard and Capital World Investors increased holdings by 3.5% and 32.5%, respectively. Insider sales include EVP April Miller, who sold 40,256 shares for $4 million. Analysts maintain a cautious outlook, with 25 ‘Hold’ ratings and only 12 ‘Buy’ recommendations among 41 tracked by MarketBeat. The average price target of $81.52 trails the current stock price, though JPMorgan raised its target to $45 and Jefferies to $80. Citigroup projects the server CPU market could reach $132 billion by 2030, positioning Intel for long-term growth. The disconnect between Intel’s stock performance and analyst targets reflects investor optimism tempered by fundamental concerns. While revenue growth and earnings beats support the rally, persistent profitability issues and mixed institutional activity leave Wall Street skeptical about sustained gains.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.